These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 13700311)

  • 1. [Bone marrow transplantation after dimethyl myleran as a method of evaluation of the effect of mutagenetic influences on transplantation antigenicity of hematopoietic cells].
    FLOERSHEIM GL
    Med Exp Int J Exp Med; 1961; 4():85-92. PubMed ID: 13700311
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunogenetic aspects of marrow cell transplantation in rats after administration of myleran].
    Dunjic A; Linchet G; Cuvelier AM
    Pathol Biol (Paris); 1970 Oct; 18(19):871-80. PubMed ID: 4922807
    [No Abstract]   [Full Text] [Related]  

  • 3. Curative effect of homologous bone marrow transfusions in rats receiving lethal doses of 'Myleran'.
    DUNJIC A
    Nature; 1962 May; 194():493-5. PubMed ID: 13888476
    [No Abstract]   [Full Text] [Related]  

  • 4. [Restoration of hematopoiesis following a lethal dose of dimethyl myleran by isologic bone marrow transplantation in mice. Experiments on modification of intolerance to homologous bone marrow by 6-mercaptopurine, aminochlorambucil and cortisone].
    FLOERSHEIM GL; ELSON LA
    Acta Haematol; 1961; 26():233-45. PubMed ID: 13893617
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival of rat bone marrow cells after treatment with myleran and endoxan.
    Dunjic A; Cuvelier AM
    Exp Hematol; 1973; 1(1):11-21. PubMed ID: 4608438
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxicologic and marrow transplantation studies in rhesus monkeys given dimethyl myleran.
    Buckner CD; Dillingham LA; Giddens WE; Thomas ED
    Exp Hematol; 1975 Sep; 3(5):275-88. PubMed ID: 1100421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran.
    Kolb HJ; Storb R; Weiden PL; Ochs HD; Kolb H; Graham TC; Floersheim GL; Thomas ED
    Biomedicine; 1974 Sep; 20(5):341-51. PubMed ID: 4615750
    [No Abstract]   [Full Text] [Related]  

  • 8. Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan.
    Kim SE; Lee JH; Choi SJ; Lee JH; Ryu SG; Lee KH
    Haematologica; 2005 Feb; 90(2):285-6. PubMed ID: 15710597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients.
    Askenasy N; Yolcu ES; Shirwan H; Wang Z; Farkas DL
    Stem Cells; 2003; 21(2):200-7. PubMed ID: 12634416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHORTENING OF THE SPAN OF LIFE OF RATS BY 'MYLERAN'.
    DUNJIC A
    Nature; 1964 Aug; 203():887-8. PubMed ID: 14204090
    [No Abstract]   [Full Text] [Related]  

  • 11. Weakening of genetic resistance. II. The effect of injection of the macrophage toxic agents silica and carragheenan and the cytostatic drugs cyclophosphamide, busulphan and vinblastin.
    Buurman WA; van Bruggen I
    Exp Hematol; 1976 Nov; 4(6):382-92. PubMed ID: 186293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD; Ploemacher RE
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Curative action of isologous bone marrow in rats having received a lethal dose of myleran. Relation between the number of cells of transfused bone marrow and survival].
    DUNJIC A; MAISIN J
    Rev Fr Etud Clin Biol; 1960 Mar; 5():268-72. PubMed ID: 13818657
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan.
    Basch RS; Quito FL; Beh J; Hirst JA
    Stem Cells; 1997; 15(4):314-23. PubMed ID: 9253116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxication of Myleran in rats by the homologous bone marrow].
    HLAVAYOVA E
    Neoplasma; 1960; 7(Suppl 1)():137-41. PubMed ID: 13714732
    [No Abstract]   [Full Text] [Related]  

  • 17. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of juvenile chronic granulocytic leukemia with marrow transplantation.
    Sanders JE; Buckner CD; Stewart P; Thomas ED
    Pediatrics; 1979 Jan; 63(1):44-6. PubMed ID: 375170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of haemopoietic and microenvironmental populations of mouse bone marrow after treatment with busulphan.
    Molineux G; Testa NG; Massa G; Schofield R
    Biomed Pharmacother; 1986; 40(6):215-20. PubMed ID: 3539222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effect of four cytotoxic agents on granulocytic and erythroid repopulating ability of rat bone marrow.
    Constable TB; Blackett NM
    J Natl Cancer Inst; 1972 Apr; 48(4):941-8. PubMed ID: 4554117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.